- Conditions: cUTI; Complicated Urinary Tract Infection; Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - Condition: Scorpion Sting Envenomation
Intervention: Biological: Antivenin Centruroides (scorpion) equine immune F(ab')2
Sponsors: Instituto Bioclon S.A. de C.V.; Instituto Bioclon S.A. de C.V.; University of Arizona; Instituto de Biotecnologia UNAM
Completed - verified May 2012 - Condition: Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem; Drug: Either 500 mg of Ciprofloxacin (oral); Drug: or 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - Condition: Skin Irritancy Tests
Interventions: Procedure: 10% lactic acid test; Procedure: Placebo
Sponsors: Universidad Autonoma de San Luis Potosí; Universidad Autonoma de San Luis Potosí; Hospital Central "Dr. Ignacio Morones Prieto"
Recruiting - verified May 2012 - Condition: Neoplasms
Intervention: Drug: bevacizumab
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: MEMP1972A; Drug: MEMP1972A; Drug: MEMP1972A; Drug: placebo
Sponsors: Genentech; Genentech
Not yet recruiting - verified April 2012 - Conditions: Radiation Pneumonitis; Locally Advanced Lung Cancer
Intervention:
Sponsors: Instituto Nacional de Cancerologia de Mexico; Instituto Nacional de Cancerologia de Mexico; National Council of Science and Technology, Mexico
Not yet recruiting - verified April 2012

Clinical Trial Locations 